Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer

por Gentilini, L.D., Jaworski, F.M., Tiraboschi, C., Pérez, I.G., Kotler, M.L., Chauchereau, A., Laderach, D.J., Compagno, D.

Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer

por Chauchereau, A., Al Nakouzi, N., Gaudin, C., Le Moulec, S., Compagno, D., Auger, N., Bénard, J., Opolon, P., Rozet, F., Validire, P., Fromont, G., Fizazi, K.

A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease

por Laderach, D.J., Gentilini, L.D., Giribaldi, L., Delgado, V.C., Nugnes, L., Croci, D.O., Al Nakouzi, N., Sacca, P., Casas, G., Mazza, O., Shipp, M.A., Vazquez, E., Chauchereau, A., Kutok, J.L., Rodig, S.J., Elola, M.T., Compagno, D., Rabinovich, G.A.

Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer

por Garrido, M.F., Martin, N.J.-P., Bertrand, M., Gaudin, C., Commo, F.E., Kalaany, N.E., Nakouzi, N.A., Fazli, L., Nery, E.D., Camonis, J., Perez, F., Lerondel, S., Le Pape, A., Compagno, D., Gleave, M., Loriot, Y., Desaubry, L., Vagner, S., Fizazi, K., Chauchereau, A.